This website uses cookies. By continuing you are agreeing to our privacy policy.

Anxiety and COPD Evaluation (ACE Trial)

Anxiety is a common comorbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) which negatively affects quality of life and predicts mortality. Since many somatic symptoms of COPD and anxiety overlap, using standard anxiety assessments designed for the general population may not properly identify anxiety in COPD sufferers. Researchers developed the Anxiety Inventory for Respiratory Disease (AIR) questionnaire to better detect anxiety in this population. The goal of the Anxiety and COPD Evaluation (ACE) study is to validate this scale by administering the AIR questionnaire to 200 participants with COPD. Psychological, health status, cognitive, medical, and respiratory measures will also be collected.

View more ACRC trials »


    Page Last Updated: December 6, 2019

    Red button with telephone
    Ask An Expert

    Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

    Get help
    Red button of two hand prints
    We need your generous support

    Make a difference by delivering research, education and advocacy to those impacted by lung disease.

    Button of turquoise LUNG FORCE swirl
    What is LUNG FORCE?

    LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

    Get involved
    Join the fight for healthy lungs and healthy air.
    Donate Now.